Use access key #2 to skip to page content.
$68.94 0.98 (1.44%)
7/18/2008 4:00 PM

Baxter International, Inc. (BAX)

CAPS Rating:
***

The Company provides medical products and services. Its medical devices, pharmaceuticals and biotechnology assists healthcare professionals and their patients in the treatment of complex medical conditions.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BAX

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

300 Outperforms
22 Underperforms
 

All-Stars

109 Outperforms
9 Underperforms
 

Wall Street

9 Outperforms
1 Underperforms
 

Players bullish on BAX are also bullish on:

Players bearish on BAX are also bearish on:

Ticker Tags

Medical Instruments & Supplies (112), Large Cap (467), Deerfield (2), S&P 500 (481), Supplies (66), Dividend (202), Medical Device (42), Illinois (19), Six Sigma® (37), Chicago (31)
Suggest a tag

Baxter International, Inc. At A Glance

Current Price: $68.94
Last Trade Time: 7/18/2008 4:00 PM
Open: $68.12
Previous Close: $67.96
Daily Range: $67.38 - $69.05
52-Week Range: $49.30 - $69.66
Volume: 6,600,307
Market Cap: $42.64B
P/E Ratio: 23.27
Compare Our Special Broker Offers!

Stock Trends

BAX VS S&P 500 (SPY)

BAX 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for BAX

More Headlines...

Top Bull Pitch

Recs

1

Baxter International, Inc. (BAX)

Avatar ethanbryson (47.91) Submitted: 1/06/08 11:10 AM

I am familiar with and use daily in my work many of the high quality products Baxter produces. I have followed them for a few years and recently opened a position now at $58. I think they have the potentail for steady, though not stellar, growth from here and though I was able to trim my position at...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Baxter International, Inc. (BAX)

Avatar kahunacfa (< 20) Submitted: 2/14/08 4:04 PM

Baxter is being investigated by the FDA over the active ingrediant in their anti-coaglation agent Heperin. The active ingredient is manufactured for Baxter, under contract, in China.





Gentlemen - Start your Lawyers!





Kahuna,CFA

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 36 :   1 2 3 4 5 Next »

Recs

0

 (BAX)

Avatar oxsigtech (76.20) Submitted: 7/15/08 5:49 PM : Outperform Start Price: $67.00 BAX Score: -0.64

Baxter is a great name.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BAX)

Avatar ThatGuitarGuy (57.56) Submitted: 7/08/08 11:19 PM : Outperform Start Price: $65.47 BAX Score: 6.44

I work for this company and I've seen how they operate and it's one of the best companies to work for. The benefits provided is great, and the way they treat their employees will surely encourage them to work hard for this company.

In a world where the economy is having a rough time, Baxter has many different things in place to continue (and actually increase) business, (plasma donation centers/drugs for example.)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BAX)

Avatar 9ballkid (< 20) Submitted: 7/01/08 12:39 PM : Outperform Start Price: $63.90 BAX Score: 7.92

New CANCER drugs

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BAX)

Avatar OxyDent (< 20) Submitted: 5/23/08 3:05 PM : Outperform Start Price: $60.22 BAX Score: 23.18

healtcare potential to gow more

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BAX)

Avatar PapaShaq (89.17) Submitted: 5/13/08 6:07 PM : Underperform Start Price: $61.12 BAX Score: -23.40

No pep

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 36 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 10 of 10  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 82.55 07/09/08 Underperform 3W $65.00+6.06%-1.02%-7.08
TrackLeerinkSwan 97.99 06/23/08 Outperform NS $62.78+9.81%-4.57%+14.38
TrackWMBlair < 20 04/18/08 Outperform NS $61.32+12.43%-9.00%+21.43
TrackCitigroup 88.93 01/08/08 Outperform NS $60.19+14.53%-11.28%+25.81
TrackBearStearns 90.40 10/19/07 Outperform NS $58.47+17.91%-17.13%+35.04
TrackEdwardOwens 98.95 09/30/07 Outperform NS $55.66+23.86%-17.39%+41.24 Toggle the visibility of 60-Second Pitch and replies
TrackJohnRogers < 20 09/30/07 Outperform NS $55.66+23.86%-17.39%+41.24 Toggle the visibility of 60-Second Pitch and replies
TrackRichAster 82.72 09/30/07 Outperform NS $55.66+23.86%-17.39%+41.24 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 89.89 09/30/07 Outperform NS $55.66+23.86%-17.39%+41.24 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 98.58 09/30/07 Outperform NS $55.66+23.86%-17.39%+41.24 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 10 of 10  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners